US chemical group Celanese and Germany’s Secarna Pharmaceuticals, an antisense drug discovery and development company, entered a research collaboration for the...
27.03.2020
- Secarna Pharmaceuticals, a German biopharmaceuticals company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address...
10.09.2018
- Germany’s Secarna Pharmaceuticals and Firebrand Therapeutics of the US have entered a co-development agreement for novel cancer therapies. The target is to combine Secarna's...
